812 650

Cited 45 times in

18F-PSMA-1007 PET/CT Detects Micrometastases in a Patient With Biochemically Recurrent Prostate Cancer

DC Field Value Language
dc.contributor.author윤미진-
dc.date.accessioned2018-07-20T08:08:06Z-
dc.date.available2018-07-20T08:08:06Z-
dc.date.issued2017-
dc.identifier.issn1558-7673-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/160863-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherElsevier-
dc.relation.isPartOfCLINICAL GENITOURINARY CANCER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.title18F-PSMA-1007 PET/CT Detects Micrometastases in a Patient With Biochemically Recurrent Prostate Cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Nuclear Medicine-
dc.contributor.googleauthorFrederik L. Giesel-
dc.contributor.googleauthorClaudia Kesch-
dc.contributor.googleauthorMijin Yun-
dc.contributor.googleauthorJens Cardinale-
dc.contributor.googleauthorUwe Haberkorn-
dc.contributor.googleauthorKlaus Kopka-
dc.contributor.googleauthorClemens Kratochwil-
dc.contributor.googleauthorBoris A. Hadaschik-
dc.identifier.doi10.1016/j.clgc.2016.12.029-
dc.contributor.localIdA02550-
dc.relation.journalcodeJ00575-
dc.identifier.eissn1938-0682-
dc.identifier.pmid28131751-
dc.subject.keywordBiochemical recurrence-
dc.subject.keywordImaging-
dc.subject.keywordPositron emission tomography-
dc.subject.keywordRadiotracer-labeled prostate-specific membrane antigen-
dc.subject.keywordStaging-
dc.contributor.alternativeNameYun, Mi Jin-
dc.contributor.affiliatedAuthorYun, Mi Jin-
dc.citation.volume15-
dc.citation.number3-
dc.citation.startPagee497-
dc.citation.endPagee499-
dc.identifier.bibliographicCitationCLINICAL GENITOURINARY CANCER, Vol.15(3) : e497-e499, 2017-
dc.identifier.rimsid60747-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Nuclear Medicine (핵의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.